UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response:
0.5
1. Name and Address of Reporting Person*LUND-JURGENSEN KIRSTEN
(Last)
(First)
(Middle)
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
(Street)
NEW YORK
NY
10017
(City)
(State)
(Zip)
2. Date of Event Requiring Statement
(Month/Day/Year)
12/30/2016
3. Issuer Name and Ticker or Trading Symbol
PFIZER INC
[ PFE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director
10% Owner
Officer (give title below)
Other (specify below)
Executive Vice President
5. If Amendment, Date of Original Filed
(Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr.
4)
2.
Amount of Securities Beneficially Owned (Instr.
4)
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
4. Nature of Indirect Beneficial Ownership (Instr.
5)
Common Stock
13,756
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
6. Nature of Indirect Beneficial Ownership (Instr.
5)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares
Phantom Stock Units
(1)
(1)
Common Stock
61,607
(2)
Stock Appreciation Rights
02/24/2018(3)
02/24/2018(3)
Common Stock
15,957
$18.9
Stock Appreciation Rights
02/23/2017(4)
02/23/2017(4)
Common Stock
21,238
$21.03
Stock Appreciation Rights
02/23/2019(3)
02/23/2019(3)
Common Stock
18,004
$21.03
Stock Appreciation Rights
02/28/2018(4)
02/28/2018(4)
Common Stock
19,273
$27.37
Stock Appreciation Rights
02/28/2020(3)
02/28/2020(3)
Common Stock
15,996
$27.37
Stock Appreciation Rights
02/25/2021(4)
02/25/2021(4)
Common Stock
15,071
$30.59
Stock Appreciation Rights
02/25/2023(3)
02/25/2023(3)
Common Stock
13,469
$30.59
Stock Appreciation Rights
02/27/2019(4)
02/27/2019(4)
Common Stock
15,164
$32.23
Stock Appreciation Rights
02/27/2021(3)
02/27/2021(3)
Common Stock
12,078
$32.23
Stock Appreciation Rights
02/26/2020(4)
02/26/2020(4)
Common Stock
14,063
$34.59
Stock Appreciation Rights
02/26/2022(3)
02/26/2022(3)
Common Stock
11,723
$34.59
Explanation of Responses:
1. The units, held under the Deferred Compensation Plan are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
2. Each unit represents one phantom share of common stock.
3. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
4. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Remarks:
poallj16.htm
Susan E. Grant, by power of atty., for Kirsten Lund-Jurgensen
01/04/2017
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person,
see
Instruction
(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.